Chinese expert consensus on the application of intravenous immunoglobulin in hematological diseases

Chinese expert consensus on the application of intravenous immunoglobulin in hematological diseases

Intravenous immunoglobulin (IVIG), first developed for the treatment of patients with antibody deficiencies, is now widely used in clinical practice, especially in hematological and immune system diseases, and its application in hematological oncology chemotherapy, cellular immunotherapy and hematop...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhi Guo, Jie Zhu, Jun Wang, Liang Wang, Feifei Tang, Huiqiang Huang, Zhongjun Xia, Liqiong Liu, Danyu Wang, Nan Zhong, Huanhuan Zhou, Zhaogui Zhou, Wei Dai, Xiaojun Xu, Hao Zhou, Lijuan Deng, Jingye Meng, Zhiqiang Sun, Liang Shao, Yu J. Cao, Yansong Liu, Rong Qu, Guowei Li, Peng Chen, Hongyan Zhang, Jing Liang, Yuhua Li, Jiajun Liu, Zishan Xu, Soong Sung Inda, Xiaochen Xiang, Qingming Wu, Qiang Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-04-01
Series:Frontiers in Medicine
Subjects:
IVIG
clinical application
hematologic disorders
chimeric antigen receptor T-Cell
hematopoietic stem cell transplant (HSCT)
expert consensus
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2025.1544025/full
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Intravenous immunoglobulin (IVIG), first developed for the treatment of patients with antibody deficiencies, is now widely used in clinical practice, especially in hematological and immune system diseases, and its application in hematological oncology chemotherapy, cellular immunotherapy and hematopoietic stem cell transplantation (HSCT) is becoming more and more common. The Chinese Collaborative Group for Infection Immunology and Microecology Research Translation Collaborative Group organized relevant experts to discuss and propose the “Chinese expert consensus on the application of intravenous immunoglobulin in hematological diseases,” which was formulated based on the progress of research on the application of IVIG in blood diseases, and provides a basis for the standardization of the use of IVIG in hematologic disorders.
ISSN:2296-858X

Similar Items